Osteoporosis is a chronic and a life-threatening disease in which the microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone brittleness and risk of bone fractures and cracks. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. Anti-osteoporosis therapies increase the bone mineral density and stops or slow down the loss of bone tissue. The therapy can decrease the threat of bone fractures over a period of time. The type of action of this fracture healing anti-osteoporosis therapy is usually by the anti-catabolic or anabolic drugs.
Rise in incidence of osteoporosis patients and growing prevalence of bone diseases resulting out of changing lifestyle are some factors fuelling the market growth. Additionally, growth in investments in R&D for generation of drugs and increasing awareness about osteoporosis are also adding to the growth of osteoporosis market.
Global Anti-Osteoporosis Therapy and Fracture Healing market is segregated on the basis of drug type as calcitonin, biologics, bisphosphonates, hormone replacement therapy, and anabolics. Based on route of administration, the global Anti-Osteoporosis Therapy and Fracture Healing market is segmented in injectable and oral. The report also bifurcates global Anti-Osteoporosis Therapy and Fracture Healing market based on distribution channel in private clinics, hospital pharmacies, drug stores, retail pharmacies and e-commerce.
Global Anti-Osteoporosis Therapy and Fracture Healing market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Anti-Osteoporosis Therapy and Fracture Healing market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Actavis plc., Merck and Company Inc., GlaxoSmithKline Plc. are among the major players in the global Anti-Osteoporosis Therapy and Fracture Healing market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Anti-Osteoporosis Therapy and Fracture Healing Market has been segmented as below:
Anti-Osteoporosis Therapy and Fracture Healing Market, by Drug Type
Anti-Osteoporosis Therapy and Fracture Healing Market, by Route of Administration
Anti-Osteoporosis Therapy and Fracture Healing Market, by Distribution Channel
Anti-Osteoporosis Therapy and Fracture Healing Market, By Region
The report covers:
Report scope:
Global Anti-Osteoporosis Therapy and Fracture Healing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Anti-Osteoporosis Therapy and Fracture Healing market share. Major industry players with significant revenue share include GlaxoSmithKline Plc., Eli Lilly and Company, Actavis plc. Etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Continuous Peripheral Nerve Block Catheter Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. High investment in R&D
4.2.2. Increasing awareness about osteoporosis
4.2.3. Increasing prevalence of osteoporosis in aged women
4.3. Restraints
4.3.1. Complications and side effects with treatment
5. Anti-Osteoporosis Therapy and Fracture Healing Market, By Drug Type
5.1. Key Points
5.2. Calcitonin
5.3. Biologics
5.4. Bisphosphonates
5.5. Hormone replacement Therapy
5.6. Anabolics
6. Anti-Osteoporosis Therapy and Fracture Healing Market, By route of Administration
6.1. Key Points
6.2. Injectable
6.3. Oral
7. Anti-Osteoporosis Therapy and Fracture Healing Market, By Distribution Channel
7.1. Key Points
7.2. Private Clinics
7.3. Hospital Pharmacies
7.4. Drug Stores
7.5. Retail Pharmacies
7.6. E-Commerce
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. GlaxoSmithKline plc
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Actavis plc
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Merck and Company Inc.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Eli Lilly and Company
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Amgen Inc.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Pfizer, Inc.
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Novartis International AG.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
The Anti-Osteoporosis Therapy and Fracture Healing Market has been segmented as below:
Anti-Osteoporosis Therapy and Fracture Healing Market, by Drug Type
Anti-Osteoporosis Therapy and Fracture Healing Market, by Route of Administration
Anti-Osteoporosis Therapy and Fracture Healing Market, by Distribution Channel
Anti-Osteoporosis Therapy and Fracture Healing Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
